Intermediate risk Myelofibrosis
Drug | Drug Name | Drug Description |
---|---|---|
DB11763 | Momelotinib | A Janus Kinase inhibitor used to treat intermediate or high-risk myelofibrosis. |
DB08877 | Ruxolitinib | A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment. |
Drug | Drug Name | Phase | Status | Count |
---|